Femasys Inc. (FEMY)
USD 1.12
(-2.61%)
USD 1.12
(-2.61%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 4.25 Million USD | 14797.07% |
| 2022 | 28.58 Thousand USD | -92.9% |
| 2021 | 402.41 Thousand USD | -59.42% |
| 2020 | 991.58 Thousand USD | -20.25% |
| 2019 | 1.24 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 4.75 Million USD | 6.38% |
| 2024 Q1 | 4.47 Million USD | 5.03% |
| 2023 FY | 4.25 Million USD | 14797.07% |
| 2023 Q2 | - USD | 0.0% |
| 2023 Q1 | - USD | -100.0% |
| 2023 Q4 | 4.25 Million USD | 96.32% |
| 2023 Q3 | 2.16 Million USD | 0.0% |
| 2022 Q4 | 28.58 Thousand USD | -75.31% |
| 2022 Q2 | 209.09 Thousand USD | -31.46% |
| 2022 Q1 | 305.07 Thousand USD | -24.19% |
| 2022 FY | 28.58 Thousand USD | -92.9% |
| 2022 Q3 | 115.77 Thousand USD | -44.63% |
| 2021 Q1 | 751.36 Thousand USD | -24.23% |
| 2021 FY | 402.41 Thousand USD | -59.42% |
| 2021 Q4 | 402.41 Thousand USD | -19.82% |
| 2021 Q3 | 501.91 Thousand USD | -16.85% |
| 2021 Q2 | 603.61 Thousand USD | -19.66% |
| 2020 Q1 | - USD | 0.0% |
| 2020 Q4 | 991.58 Thousand USD | 0.0% |
| 2020 FY | 991.58 Thousand USD | -20.25% |
| 2019 FY | 1.24 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 75.25 Million USD | 94.342% |
| AngioDynamics, Inc. | 3.93 Million USD | -8.103% |
| AtriCure, Inc. | 60.59 Million USD | 92.972% |
| Avinger, Inc. | - USD | -Infinity% |
| Azenta, Inc. | 60.43 Million USD | 92.954% |
| BioLife Solutions, Inc. | 18.31 Million USD | 76.745% |
| The Cooper Companies, Inc. | 2.52 Billion USD | 99.831% |
| Daxor Corporation | 755.65 Thousand USD | -463.505% |
| Ekso Bionics Holdings, Inc. | 4.83 Million USD | 11.875% |
| GlucoTrack, Inc. | 196 Thousand USD | -2072.54% |
| Harvard Bioscience, Inc. | 30.7 Million USD | 86.132% |
| Hologic, Inc. | 2.49 Billion USD | 99.829% |
| ICU Medical, Inc. | 1.57 Billion USD | 99.73% |
| Intuitive Surgical, Inc. | -82.1 Million USD | 105.187% |
| KORU Medical Systems, Inc. | 3.65 Million USD | -16.569% |
| LeMaitre Vascular, Inc. | 16.62 Million USD | 74.385% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Masimo Corporation | 871.7 Million USD | 99.512% |
| Microbot Medical Inc. | 40 Thousand USD | -10545.448% |
| Meihua International Medical Technologies Co., Ltd. | 4592.00 USD | -92630.379% |
| Merit Medical Systems, Inc. | 823.01 Million USD | 99.483% |
| Nephros, Inc. | 1.39 Million USD | -206.344% |
| NovoCure Limited | 596.24 Million USD | 99.286% |
| NEXGEL, Inc. | 513 Thousand USD | -730.054% |
| NEXGEL, Inc. | 513 Thousand USD | -730.054% |
| Singular Genomics Systems, Inc. | 67.52 Million USD | 93.694% |
| OraSure Technologies, Inc. | 11.38 Million USD | 62.608% |
| Pro-Dex, Inc. | 7.53 Million USD | 43.496% |
| Pulse Biosciences, Inc. | 8.08 Million USD | 47.339% |
| Predictive Oncology Inc. | 2.18 Million USD | -94.528% |
| Precision Optics Corporation, Inc. | 1.93 Million USD | -119.724% |
| QuidelOrtho Corporation | 2.27 Billion USD | 99.813% |
| Repligen Corporation | 510.14 Million USD | 99.165% |
| Sanara MedTech Inc. | 9.11 Million USD | 53.274% |
| STAAR Surgical Company | 31.46 Million USD | 86.468% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| Utah Medical Products, Inc. | 295 Thousand USD | -1343.451% |
| DENTSPLY SIRONA Inc. | 1.79 Billion USD | 99.763% |
| Jin Medical International Ltd. | - USD | -Infinity% |